Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept cookies
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
    Most Read
    • Erdoğan extends rule into third decade with Turkish election victory
    • US debt crisis: Joe Biden gets the deal done but at a cost
    • Republican leaders try to quell debt deal revolt as US counts down to default
    • China’s first passenger jet completes maiden commercial flight
    • Russia launches massive drone attack on Kyiv
  • US
    Sections
    • US Home
    • US Economy
    • US Companies
    • US Politics & Policy
    Most Read
    • Companies
      Sections
      • Companies Home
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
      Most Read
      • Mike Lynch uses $50mn in Darktrace shares to secure US bail
      • Canada’s big banks log 13-fold rise in loan loss provisions
      • Insolvency risk rises for larger UK companies as inflation bites
      • Sky to cut hundreds of jobs in shift from satellite TV
      • PwC suspends 9 partners over Australian tax leak scandal
    • Tech
    • Markets
      Sections
      • Markets Home
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Trading
      • Moral Money
      • ETF Hub
      Most Read
      • Après debt ceiling deal, le T-bill déluge
      • AI boom drives gains for chip stocks
      • India’s biggest alternative asset manager bets on private credit
      • A European People’s Bond could support Ukraine’s reconstruction
      • Commercial property’s big reset will present opportunities
    • Climate
    • Opinion
      Sections
      • Opinion Home
      • Columnists
      • The FT View
      • Lex
      • Obituaries
      • Letters
      Most Read
      • How to buy a global $20bn company for nothing
      • Now the UK is finally tackling ‘Londongrad’, it’s time the US upped its game
      • Citizens’ juries can help fix democracy
      • Taking an electric car on the road is still a gamble in America
      • What we get wrong about ageing and work
    • Work & Careers
      Sections
      • Work & Careers Home
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
      Most Read
      • ‘Everyone has the right to completely log off’: what bosses think about the right to disconnect
      • Wellcome Leap’s Regina Dugan: ‘Odds are irrelevant, if what you’re trying to do is important’
    • Life & Arts
      Sections
      • Life & Arts Home
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
      Most Read
      • Yes, Suella Braverman should go, but not for the reason you think
      • The UK’s best bakeries: the readers’ picks
      • GCHQ’s Jeremy Fleming: ‘Xi doesn’t want to see Putin humiliated’
      • The Michelin-starred McMuffin...
      • Four European city breaks to book now
    • HTSI
    MenuSearch
    • Home
    • World
    • US
    • Companies
    • Tech
    • Markets
    • Climate
    • Opinion
    • Work & Careers
    • Life & Arts
    • HTSI
    Financial Times
    SubscribeSign In

    Harvard Medical School

    Add to myFT Digest

    Add this topic to your myFT Digest for news straight to your inbox

    • Thursday, 6 June, 2019
      Executive education
      Google used an executive education tie-up to figure out healthcare

      Tech giant’s determination to earn doctors’ trust led to a groundbreaking partnership 

    • Monday, 4 September, 2017
      Pharmaceuticals sector
      Novartis chief exec Joe Jimenez to step down
    • Thursday, 2 June, 2016
      Pharmaceuticals sector
      Cancer researchers step up drive for earlier detection

      Ever more sophisticated means are used but can lead to problems of their own

    • Thursday, 25 February, 2016
      Recruitment
      Rushika Fernandopulle, chief executive, Iora Health

      Physician’s business plan aims to help patients heal themselves

    • Tuesday, 29 December, 2015
      Strategy
      Digital doctors: on a mission to change medicine

      Three medics and one ex-student reveal the challenges and lessons of their health-tech ventures

    • Sunday, 6 December, 2015
      Disrupters
      Excitement rises over gene editing tool, but ethical doubts remain

      Rearranging human DNA to eradicate disease could become an everyday reality

    • Friday, 14 August, 2015
      ObituaryPharmaceuticals sector
      Frances Kelsey, drug regulator who barred thalidomide, 1914-2015

      Diligent doctor who averted an American child calamity

    • Tuesday, 28 April, 2015
      MBA blogBusiness education
      Batteries low? Recharge with a power nap
    • Thursday, 15 May, 2014
      UK business & economy
      Independent experts to examine statins side-effects claims
    • Sunday, 30 June, 2013
      ReviewLife & Arts
      A highly personalised prescription

      A persuasive study of Singapore’s cost-effective medical system shows that it offers lessons – albeit limited – for other nations

    • Thursday, 4 October, 2012
      Recruitment
      ‘Creativity is vital – but it faces a sworn enemy’

      Head to head, with Christian Schroeder of Lambie-Nairn

    • Friday, 7 January, 2011
      FT Magazine
      A jumbo discovery
    • Friday, 8 October, 2010
      Life & Arts
      The art of dreaming
    • Tuesday, 11 May, 2010
      World
      Academic criticises response to swine flu
    • Thursday, 25 March, 2010
      UK schools
      Life on the edge
    • Wednesday, 6 January, 2010
      Books
      How lists of the ‘dumb stuff’ can save us from disaster
    • Friday, 12 June, 2009
      Christopher CaldwellUS society
      Addicts have made a choice
    • Tuesday, 16 December, 2008
      World
      New York proposes soda tax
    • Monday, 4 August, 2008
      Health sector
      Doctors oppose US health plan
    • Friday, 3 November, 2006
      World
      Science briefing
    • Thursday, 9 February, 2006
      Global Economy
      Cocoa flavanols diet ‘cuts cancer risk’
    • Tuesday, 27 September, 2005
      US downturn
      New plan unveiled in drive to cut US obesity
    • Sunday, 3 October, 2004
      US & Canadian companies
      Merck move ?points to FDA weakness?
    Previous page You are on page 1 Next page

    Useful links

    Support

    View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

    Legal & Privacy

    Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

    Services

    Share News Tips SecurelyIndividual SubscriptionsGroup SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on TwitterFT ChannelsFT Schools

    Tools

    PortfolioToday's Newspaper (ePaper)Alerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

    Community & Events

    FT CommunityFT Live EventsFT ForumsFT Board DirectorBoard Director Programme

    More from the FT Group

    Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2023. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
    The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
    Financial Times

    International Edition

    Subscribe for full access
    • Switch to UK Edition

    Top sections

    • Home
    • World
      • Global Economy
      • UK
      • US
      • China
      • Africa
      • Asia Pacific
      • Emerging Markets
      • Europe
      • War in Ukraine
      • Americas
      • Middle East & North Africa
      • Australia & NZ
    • US
      • US Economy
      • US Companies
      • US Politics & Policy
    • Companies
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
    • Tech
    • Markets
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Trading
      • Moral Money
      • ETF Hub
    • Climate
    • Opinion
      • Columnists
      • The FT View
      • Lex
      • Obituaries
      • Letters
    • Work & Careers
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
    • Life & Arts
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
    • Personal Finance
      • Property & Mortgages
      • Investments
      • Pensions
      • Tax
      • Banking & Savings
      • Advice & Comment
      • Next Act
    • HTSI
    • Special Reports

    FT recommends

    • Lex
    • Alphaville
    • Lunch with the FT
    • FT Globetrotter
    • #techAsia
    • Moral Money
    • Newsletters
    • Video
    • Podcasts
    • News feed
    • FT Live Events
    • FT Forums
    • Board Director Programme
    • myFT
    • Portfolio
    • Today's Newspaper (ePaper)
    • Crossword
    • Our Apps
    • Help Centre
    • Subscribe
    • Sign In